Surgery News

Use of an external saphenous vein graft support device did not improve intimal hyperplasia area in patients undergoing CABG compared with an unsupported graft, according to results from the VEST trial.

Early CABG performed 2 to 3 days after ticagrelor cessation was noninferior to delayed CABG performed at 5 to 7 days for the outcome of severe or massive perioperative bleeding in patients with ACS who required nonemergent surgery.

In patients who had mitral valve surgery but also tricuspid regurgitation or tricuspid annular dilation, performing concomitant tricuspid valve repair lowered risk for progression of tricuspid regurgitation, researchers reported.

In the AVATAR trial, patients with asymptomatic severe aortic stenosis and normal left ventricular function assigned early surgical aortic valvular replacement, compared with watchful waiting, had a lower incidence of death and CV outcomes.

Among patients with atrial fibrillation at high risk for stroke, left atrial appendage closure remained noninferior to direct oral anticoagulation for preventing major CV and neurological events out to 4 years.

Transcatheter aortic valve replacement with a self-expanding valve was noninferior to surgical AVR in intermediate-risk patients at 5 years, according to new data from the SURTAVI trial.

In the FAME 3 trial, PCI guided by fractional flow reserve failed to meet noninferiority for reduction of MACCE at 1 year compared with CABG in patients with three-vessel CAD.

In the contemporary CV clinical setting, women continue to present later and receive less aggressive care than men and experience a lower quality of life after cardiac surgery, according to an in-depth review published in Circulation.

The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with abdominal aortic aneurysms, the benefits outweigh the risks in niche populations, but not for routine use.

The FDA has classified Datascope/Getinge/Maquet’s recall of two intra-aortic balloon pumps for patients undergoing surgery as Class 1, the most serious type of recall.